Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Yan, ZX; Li, L; Wang, W; OuYang, BS; Cheng, S; Wang, L; Wu, W; Xu, PP; Muftuoglu, M; Hao, M; Yang, S; Zhang, MC; Zheng, Z; Li, J; Zhao, WL

Zhao, WL (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.

CLINICAL CANCER RESEARCH, 2019; 25 (23): 6995

Abstract

Purpose: Anti-CD19 chimeric antigen receptor (CAR) T cells represent a novel immunotherapy and are highly effective in treating relapsed/refractory B-......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索